Overview

AMG 386 Drug-Drug Interaction Study With Paclitaxel

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics of paclitaxel when given alone and in combination with AMG 386 to determine whether AMG 386 alters the pharmacokinetics of paclitaxel
Phase:
Phase 1
Details
Lead Sponsor:
Amgen
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel
Trebananib